New Year Bumper Sale @ Rs. 1 X
Carzec 12.5 Tablet is a prescription drug, available for use as Tablet. High BP are some of its major therapeutic uses. Secondary and off-label uses of Carzec 12.5 Tablet have also been mentioned below.
The right dosage of Carzec 12.5 Tablet depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Carzec 12.5 Tablet as well, which are listed below. Normally, these side effects of Carzec 12.5 Tablet are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Carzec 12.5 Tablet has a Moderate effect for pregnant women and Safe effect on lactating mothers. Warnings related to Carzec 12.5 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Carzec 12.5 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Diabetes, Bradycardia (Slow Heart Rate), Peripheral Vascular Disease (PVD) are examples of such conditions. Other conditions have been mentioned below in the Carzec 12.5 Tablet contraindications section.
Drug interactions for Carzec 12.5 Tablet have been reported in the medical literature. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Carzec 12.5 Tablet is considered not safe while driving, and is not addictive.
Carzec 12.5 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Carzec 12.5 Tablet is used -
Severe
Moderate
Mild
Is the use of Carzec 12.5 Tablet safe for pregnant women?
Carzec can have harmful effects in pregnant women. If you experience any discomfort after using Carzec, then discontinue the use and take your doctor's advice.
Is the use of Carzec 12.5 Tablet safe during breastfeeding?
Breastfeeding women can safely use Carzec.
What is the effect of Carzec 12.5 Tablet on the Kidneys?
Using Carzec does not have any harmful effects on kidneys.
What is the effect of Carzec 12.5 Tablet on the Liver?
Carzec may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Carzec 12.5 Tablet on the Heart?
Carzec may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Carzec 12.5 Tablet unless your doctor advises you to do so -
Is this Carzec 12.5 Tablet habit forming or addictive?
No, you will not get addicted to Carzec 12.5 Tablet.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Carzec 12.5 Tablet can make you feel drowsy.
Is it safe?
Yes, but take Carzec 12.5 Tablet only as per medical advice.
Is it able to treat mental disorders?
No, Carzec 12.5 Tablet cannot treat any kind of mental disorder.
Interaction between Food and Carzec 12.5 Tablet
Eating certain foods may increase the time it takes Carzec 12.5 Tablet to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Carzec 12.5 Tablet
Consult your doctor before consuming alcohol while taking Carzec 12.5 Tablet as it can have severe side effects.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 287-288
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 564
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coreg® (carvedilol)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coreg Cr® (carvedilol phosphate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Vedilol® (carvedilol)